API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Budesonide CR Pellets are multi-articulate oral dosage forms designed for controlled and sustained drug release. These pellets contain Budesonide, a corticosteroid with potent anti-inflammatory properties, commonly used in the treatment of inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis), respiratory disorders, and other inflammatory conditions.
| Component | Function |
|---|---|
| Budesonide | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethyl Cellulose / Eudragit RS / RL | Controlled release polymer coating |
| Triethyl Citrate / PEG 6000 | Plasticizer for coating |
| Talc | Anti-sticking agent in coating |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Budesonide CR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Budesonide CR Pellets are primarily used for the treatment of inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. They deliver Budesonide in a controlled manner for localized action in the gastrointestinal tract.
The typical particle size is 18–60 mesh, but it can be customized based on formulation and dosage form needs.
Yes, they are tested as USP/BP/EP standards for assay, dissolution, and related substances.
Yes, most countries require product registration with a detailed dossier (including CoA, stability data, and specifications) before import approval.